Showcases Stock ranks

ADMA Biologics Inc. (ADMA)
2.89  0.04 (1.4%) 07-02 16:00
Open: 2.9 Pre. Close: 2.85
High: 2.94 Low: 2.82
Volume: 1,679,869 Market Cap: 250M
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 2.947 - 2.966 2.966 - 2.984
Low: 2.772 - 2.797 2.797 - 2.819
Close: 2.852 - 2.891 2.891 - 2.926
Stock Technical Analysis
Target: Six months: 3.67
One year: 3.97
Support: Support1: 2.73
Support2: 2.27
Resistance: Resistance1: 3.14
Resistance2: 3.40
Pivot: 2.95
Moving Averages: MA(5): 2.92
MA(20): 2.95
MA(100): 2.90
MA(250): 3.72
MACD: MACD(12,26):
Signal(12,26,9): 0.01
%K %D: %K(14,3): 39.91
%D(3): 46.74
RSI: RSI(14): 48.51
52-Week: High: 5.484
Low: 1.45
Change(%): -23.3
Average Vol(K): 3-Month: 273754
10-Days: 241035
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

ADMA has closed above bottom band by 29.7%. Bollinger Bands are 73.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADMA's normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Tue, 23 Jun 2020
ADMA Biologics Announces Martha J. Demski Elected to Board of Directors - GlobeNewswire

Sun, 05 Jul 2020
ADMA Biologics, Inc. (NasdaqCM:ADMA) Capex to PPE Reaches 0.108224 - Pineville

Fri, 03 Jul 2020
Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment? - Yahoo Finance

Mon, 22 Jun 2020
Perhaps ADMA Biologics, Inc. (ADMA) Has Found Some Support In The Market Place - Invest Million

Fri, 03 Jul 2020
Need To Know: ADMA Biologics, Inc. (NASDAQ:ADMA) Insiders Have Been Buying Shares - Simply Wall St

Tue, 16 Jun 2020
ADMA Biologics, Inc. (ADMA) Loss -18.04% in one Year: What’s Next? - The News Heater

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 86.35
Shares Float (M) 67.92
% Held by Insiders 7.35
% Held by Institutions 47.91
Shares Short (K) 9210
Shares Short Prior Month (K) 9680
Stock Financials
EPS -0.890
Book Value (p.s.) 1.120
Profit Margin -151.18
Operating Margin -124.89
Return on Assets (ttm) -19.5
Return on Equity (ttm) -102.4
Qtrly Rev. Growth 189.1
Gross Profit (p.s.) -0.118
Sales Per Share 0.417
EBITDA (p.s.) -0.483
Qtrly Earnings Growth
Operating Cash Flow (M) -86.55
Levered Free Cash Flow (M) -69.82
Stock Valuation
PE Ratio -3.25
PEG Ratio
Price to Book value 2.58
Price to Sales 6.93
Price to Cash Flow -2.88
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator